These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 19858038
1. Intraobserver and interobserver variability of Fuhrman and modified Fuhrman grading systems for conventional renal cell carcinoma. Bektas S, Bahadir B, Kandemir NO, Barut F, Gul AE, Ozdamar SO. Kaohsiung J Med Sci; 2009 Nov; 25(11):596-600. PubMed ID: 19858038 [Abstract] [Full Text] [Related]
3. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Ficarra V, Martignoni G, Maffei N, Brunelli M, Novara G, Zanolla L, Pea M, Artibani W. Cancer; 2005 Jan 01; 103(1):68-75. PubMed ID: 15573369 [Abstract] [Full Text] [Related]
4. Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma. Al-Aynati M, Chen V, Salama S, Shuhaibar H, Treleaven D, Vincic L. Arch Pathol Lab Med; 2003 May 01; 127(5):593-6. PubMed ID: 12708904 [Abstract] [Full Text] [Related]
5. Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma. Scholten AN, Smit VT, Beerman H, van Putten WL, Creutzberg CL. Cancer; 2004 Feb 15; 100(4):764-72. PubMed ID: 14770433 [Abstract] [Full Text] [Related]
6. The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma. Finley DS, Shuch B, Said JW, Galliano G, Jeffries RA, Afifi AA, Castor B, Magyar C, Sadaat A, Kabbinavar FF, Belldegrun AS, Pantuck AJ. J Urol; 2011 Dec 15; 186(6):2168-74. PubMed ID: 22014797 [Abstract] [Full Text] [Related]
8. Histologic grading of invasive lobular carcinoma: does use of a 2-tiered nuclear grading system improve interobserver variability? Adams AL, Chhieng DC, Bell WC, Winokur T, Hameed O. Ann Diagn Pathol; 2009 Aug 15; 13(4):223-5. PubMed ID: 19608079 [Abstract] [Full Text] [Related]
9. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma. Serrano MF, Katz M, Yan Y, Kibel AS, Humphrey PA. Cancer; 2008 Aug 01; 113(3):477-83. PubMed ID: 18484589 [Abstract] [Full Text] [Related]
10. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade. Paner GP, Amin MB, Alvarado-Cabrero I, Young AN, Stricker HJ, Moch H, Lyles RH. Am J Surg Pathol; 2010 Sep 01; 34(9):1233-40. PubMed ID: 20679882 [Abstract] [Full Text] [Related]
11. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence. Delahunt B, Sika-Paotonu D, Bethwaite PB, William Jordan T, Magi-Galluzzi C, Zhou M, Samaratunga H, Srigley JR. Am J Surg Pathol; 2011 Aug 01; 35(8):1134-9. PubMed ID: 21716085 [Abstract] [Full Text] [Related]
12. Prognostic ability of simplified nuclear grading of renal cell carcinoma. Rioux-Leclercq N, Karakiewicz PI, Trinh QD, Ficarra V, Cindolo L, de la Taille A, Tostain J, Zigeuner R, Mejean A, Patard JJ. Cancer; 2007 Mar 01; 109(5):868-74. PubMed ID: 17262800 [Abstract] [Full Text] [Related]
13. Application of simplified Fuhrman grading system in clear-cell renal cell carcinoma. Hong SK, Jeong CW, Park JH, Kim HS, Kwak C, Choe G, Kim HH, Lee SE. BJU Int; 2011 Feb 01; 107(3):409-15. PubMed ID: 20804473 [Abstract] [Full Text] [Related]
14. Grading systems in renal cell carcinoma. Novara G, Martignoni G, Artibani W, Ficarra V. J Urol; 2007 Feb 01; 177(2):430-6. PubMed ID: 17222604 [Abstract] [Full Text] [Related]
15. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Sika-Paotonu D, Bethwaite PB, McCredie MR, William Jordan T, Delahunt B. Am J Surg Pathol; 2006 Sep 01; 30(9):1091-6. PubMed ID: 16931953 [Abstract] [Full Text] [Related]
16. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Gudbjartsson T, Hardarson S, Petursdottir V, Thoroddsen A, Magnusson J, Einarsson GV. Eur Urol; 2005 Oct 01; 48(4):593-600. PubMed ID: 15964127 [Abstract] [Full Text] [Related]
17. Qualitative and quantitative histopathology in transitional cell carcinomas of the urinary bladder. An international investigation of intra- and interobserver reproducibility. Sørensen FB, Sasaki M, Fukuzawa S, Yamabe H, Olsen S, Yoshida O. Lab Invest; 1994 Feb 01; 70(2):242-54. PubMed ID: 8139265 [Abstract] [Full Text] [Related]
18. A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma. Sun M, Lughezzani G, Jeldres C, Isbarn H, Shariat SF, Arjane P, Widmer H, Pharand D, Latour M, Perrotte P, Patard JJ, Karakiewicz PI. Eur Urol; 2009 Nov 01; 56(5):775-81. PubMed ID: 19573980 [Abstract] [Full Text] [Related]
19. Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis. Becker A, Hickmann D, Hansen J, Meyer C, Rink M, Schmid M, Eichelberg C, Strini K, Chromecki T, Jesche J, Regier M, Randazzo M, Tilki D, Ahyai S, Dahlem R, Fisch M, Zigeuner R, Chun FK. Eur J Surg Oncol; 2016 Mar 01; 42(3):419-25. PubMed ID: 26520403 [Abstract] [Full Text] [Related]
20. [Usefulness of new schemes to group Fuhrman grades in clinical practice for clear cell renal tumour]. Morán E, Rogel R, Soto A, Ruiz-Cerdá JL, Budía A, Salom JV, Jiménez-Cruz JF. Actas Urol Esp; 2012 Jun 01; 36(6):352-8. PubMed ID: 22266258 [Abstract] [Full Text] [Related] Page: [Next] [New Search]